Netupitant
Back to searchMolecule Structure
Scientific Name
Netupitant
Description of the Drug
Netupitant is an antiemetic agent used in combination with palonosetron to prevent acute and delayed vomiting and nausea caused by chemotherapy.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB09048
http://www.drugbank.ca/drugs/DB09048
Brand Name(s)
Not Available
Company Owner(s)
Helsinn Healthcare Sa
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Neurokinin 1 receptor | SINGLE PROTEIN | ANTAGONIST | CHEMBL249 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL445804 |
| Human Metabolome Database | HMDB0255552 |
| DrugBank | DB09048 |
| PubChem: Thomson Pharma | 15109574 |
| PubChem | 6451149 |
| LINCS | LSM-45459 |
| Nikkaji | J2.298.344J |
| PDBe | GAW |
| BindingDB | 50178574 |
| EPA CompTox Dashboard | DTXSID50183271 |
| DrugCentral | 4898 |
| ChemicalBook | CB71483126 |
| Guide to Pharmacology | 5742 |
| rxnorm | NETUPITANT |
| ChEBI | 85155 |
| ZINC | ZINC000011681563 |
